SANDS Study

SANDS Study
Black Hills Center for American Indian Health
Jeffrey Henderson, MD, Principal Investigator

The Stop Atherosclerosis in Native Diabetics Study (SANDS) is a 5-year, multi-center, randomized clinical trial focused on cardiovascular disease prevention in American Indians and Alaska Natives with Type 2 diabetes, 40 years of age and older. The majority of CVD cases in American Indians occur in individuals with diabetes. It is therefore imperative that intervention strategies to reduce CVD be developed and validated in this population. The primary endpoint of the SANDS Study is carotid intimal-medial thickness. Secondary endpoints include cardiac function measures by echocardiography, lipoproteins, albuminuria, and C-reactive protein. MBIRI conducts the ultrasound studies for the Dakota SANDS study.